Angiogenesis Inhibition

Liersch, Rüdiger (EDT); Berdel, Wolfgang E. (EDT); Kessler, Torsten (EDT)

ISBN 10: 3642261434 ISBN 13: 9783642261435
Published by Springer, 2012
Used Soft cover

From GreatBookPrices, Columbia, MD, U.S.A. Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

AbeBooks Seller since April 6, 2009

This specific item is no longer available.

About this Item

Description:

Unread book in perfect condition. Seller Inventory # 18600762

Report this item

Synopsis:

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.

From the Back Cover:

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies.

This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Angiogenesis Inhibition
Publisher: Springer
Publication Date: 2012
Binding: Soft cover
Condition: As New

Top Search Results from the AbeBooks Marketplace